Arcosa, Inc. current report, 03 March 2022

Arcosa, Inc. Form 8-K Summary

Business context and reporting period

Arcosa filed this Form 8-K on March 3, 2022, with the report signed on March 7, 2022. The filing concerns executive and employee compensation arrangements, not quarterly or annual financial results.

Key financial metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.

Material changes versus the prior comparable period

  • On March 3, 2022, Arcosa’s Board approved the 2022 Change in Control Severance Plan.
  • The plan replaced the 2018 Change in Control Severance Plan, which expired on December 6, 2021.
  • The plan applies to the Chief Executive Officer, Chief Financial Officer, Chief Legal Officer, group presidents, and other employees designated by the Board’s Human Resources Committee.
  • The plan has a three-year term and automatically renews for one-year extensions unless terminated by Arcosa.

Plan terms, outlook, risks, and unusual items

  • The plan generally uses a “double trigger”: a change in control and a qualifying termination must both occur for severance or post-December 6, 2018 equity-award acceleration.
  • Qualifying terminations include termination by Arcosa without Cause or resignation by the participant for Good Reason within six months before and in connection with a change in control, or within two years after a change in control.
  • Cash severance equals the participant’s applicable multiple of base salary plus target annual incentive compensation, or in certain circumstances actual annual incentive compensation, plus a prorated annual incentive bonus based on target performance. The multiples are three times for the CEO, two times for the CFO, Chief Legal Officer, and group presidents, and 1.5 times for other participants.
  • Eligible participants may receive full vesting of outstanding unvested stock awards granted after December 6, 2018 and full vesting of benefits under outstanding retirement or deferred compensation arrangements.
  • Medical, dental, vision, health, and life insurance coverage may continue for up to 24 months, subject to specified conditions, along with executive outplacement services capped at $15,000.
  • Benefits require execution of a release in favor of Arcosa. Participants are subject to 12-month non-competition, non-solicitation, and non-recruitment covenants, plus continuing confidentiality and non-disparagement obligations.
  • The plan does not provide excise-tax gross-ups. Payments may be reduced if necessary to avoid or reduce “golden parachute” excise taxes when doing so produces a greater after-tax benefit for the participant.

Most important facts to verify

  • Review Exhibit 10.1 for the complete definitions of Change in Control, Cause, Good Reason, covered participants, and payment calculations.
  • Confirm the plan’s renewal and termination provisions and the circumstances that activate the double-trigger benefits.
  • Assess the potential cash, equity, benefit-continuation, and tax-related costs in a future change-in-control scenario.
  • Verify whether any additional employees have been designated for coverage by the Human Resources Committee.